WebOct 6, 2004 · LINCOLNSHIRE, Ill. (October 7, 2004) – Takeda Pharmaceutical Company Limited (“Takeda”), the Osaka, Japan-based parent company of Takeda Pharmaceuticals North America, Inc. (TPNA), has entered into an alliance agreement with U.S. based BioNumerik Pharmaceuticals, Inc., to market Tavocept™ (dimesna), a Phase 3 … WebHij zit momenteel in de raden van bestuur van BioNumerik Pharmaceuticals en Spurs Sports & Entertainment. Leininger heeft ook geïnvesteerd in onroerendgoed-en voedingsbedrijven in Texas , zoals Promised Land Foods, ... Inc. Daarnaast is hij mede-eigenaar van de San Antonio Spurs. ...
BioNumerik Pharmaceuticals, Inc. Commences Global Phase III ... - BioSpace
WebJun 14, 2012 · SAN ANTONIO, June 14, 2012 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced the appointment of Mr. Steve Carchedi to BioNumerik's Board of Directors.. Mr. Carchedi brings extensive pharmaceutical industry and oncology product commercialization experience to the … WebNov 18, 2024 · BioNumerik Pharmaceuticals, Inc. engages in the discovery, … hassan soueidan
Ryan Dokich - Bionumerik Pharmaceuticals, Inc., San Antonio
WebApr 13, 2024 · Overview The breast cancer market is anticipated to reach USD 7,532 Million by 2030 at 9.2% CAGR during the forecast period 2024-2030. WebBionumerik Pharmaceuticals designs and develops small molecule drugs for the … WebMar 18, 2008 · SAN ANTONIO and TOKYO, March 18 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") and ASKA Pharmaceutical Co., Ltd. ("ASKA") today announced the results of a Phase III clinical trial of putty tools